Fennec Pharmaceuticals Inc.
- Last sale
- Nov 9, 2026 · +10.62%
- Market cap
- $381.38M
- 35.22M shares
- Filings
- 855
Q3 2026−6.1% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2014derivedN/M FY13 yoy
Q3 2026N/M FY25 yoy
Q3 2026+38.1% FY25 yoy
- $381.38M
- 188.1×
- 5.7×
- 7.8×
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 9, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $44,642,000 | reported | |
| FY 2024 | 2024-12-31 | $47,538,000 | reported | |
| FY 2023 | 2023-12-31 | $21,252,000 | reported | |
| FY 2022 | 2022-12-31 | $1,535,000 | reported | |
| FY 2019 | 2020-12-31 | $200,000 | reported | |
| FY 2018 | 2018-12-31 | $0 | reported | |
| FY 2017 | 2017-12-31 | $0 | reported | |
| FY 2016 | 2016-12-31 | $0 | reported | |
| FY 2015 | 2015-12-31 | $0 | reported | |
| FY 2014 | 2014-12-31 | $0 | reported | |
| FY 2013 | 2013-12-31 | $0 | reported |
Segments
Products
LineFY2025ShareChange
PEDMARK$44.64M100%+50.9%
Eniluracil royalty———
Total$44.64M
Biological products, except diagnostic substances
Fennec Pharmaceuticals Inc. is the 44th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
IVVDInvivyd, Inc.$53.4M110.5%98.2%$165.9MPLXProtalix BioTherapeutics, Inc.$52.7M1.2%12.5%$248.7MBSEMBioStem Technologies, Inc.$47.5M31.8%13.9%$24.7M
FENCFennec Pharmaceuticals Inc. (this company)$44.6M6.1%21.8%$381.4M
CHRSCoherus Oncology, Inc.$42.2M59.8%398.4%$83.4MEDITEditas Medicine, Inc.$40.5M25.4%395.0%$329.5MVYGRVoyager Therapeutics, Inc.$40.4M49.5%296.5%$105.8MSGMOQSangamo Therapeutics, Inc$39.6M31.6%310.8%$58.0MKYMRKymera Therapeutics, Inc.$39.2M16.7%794.0%$10.9BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Fennec Pharmaceuticals Inc. · CIK 1211583 · Engraved from SEC EDGAR